Kiến thức về virus Herpes, Poliovirus và Hepatitis

Understanding Herpesviruses, Poliovirus, and Hepatitis B Virus

Welcome to this comprehensive medical course that explores three important viral families: the Herpesviridae, Poliovirus (a member of the Picornaviridae), and the Hepatitis B virus (HBV). This module is designed for students of general medicine and pathology, providing clear explanations of viral structure, replication, pathogenic mechanisms, and transmission pathways. By the end of the lesson, you will be able to answer key quiz questions confidently and apply this knowledge in clinical contexts.

1. Herpesviridae: Classification and Key Characteristics

The Herpesviridae family comprises large, enveloped DNA viruses with a characteristic icosahedral capsid. They share several common features:

• Genome: Double‑stranded DNA (dsDNA) that is linear and ranges from 125 to 250 kilobase pairs.
• Capsid: An icosahedral capsid composed of 162 capsomeres, forming a T=16 symmetry.
• Envelope: A lipid bilayer derived from the host cell nuclear membrane, studded with glycoproteins essential for cell entry.

These structural traits influence the virus’s ability to establish latency, evade the immune system, and cause distinct clinical syndromes.

2. Herpesviruses that Cause Cytopathic Effects in Cell Culture

Not all herpesviruses produce visible cytopathic effects (CPE) when grown in vitro. The quiz highlights the viruses that induce cell lysis and syncytia formation in cultured cells:

• Cytomegalovirus (CMV): A member of the Betaherpesvirinae subfamily, CMV is notorious for causing large, basophilic intranuclear inclusions and cell enlargement ("owl’s eye" appearance).
• Epstein‑Barr virus (EBV): Belonging to the Gammaherpesvirinae, EBV can trigger transformation of B‑lymphocytes, leading to the formation of lymphoblastoid cell lines that display pronounced CPE.

Both CMV and EBV are capable of inducing cellular apoptosis and necrosis, which is why they are the correct answers to the quiz question about viruses that cause “tan tế bào” (cell lysis) in culture.

3. Herpesviruses that Promote Lymphocyte Proliferation

Among the herpesviruses, Epstein‑Barr virus (EBV) is uniquely associated with the proliferation of lymphocytes. EBV infects CD21‑positive B cells and drives them into the S phase, resulting in:

• Formation of immortalized B‑cell lines (e.g., the Raji and Daudi cell lines).
• Clinical manifestations such as infectious mononucleosis and, in chronic infections, association with lymphomas (e.g., Burkitt lymphoma, Hodgkin lymphoma).

This proliferative effect distinguishes EBV from other herpesviruses like HSV‑1, HSV‑2, and VZV, which primarily cause epithelial or neuronal lesions without marked lymphocyte expansion.

4. Structural Details of the Herpes Simplex Virus (HSV) Capsid

The capsid of HSV is a hallmark of the Herpesviridae family. It is:

• Icosahedral with 162 capsomeres arranged in a T=16 lattice.
• Composed of a protein shell that protects the dsDNA genome and provides attachment sites for the tegument proteins.

This precise arrangement is essential for the virus’s stability and for the orderly packaging of its large genome. Understanding capsid architecture aids in the development of antiviral agents that target capsid assembly.

5. Poliovirus: Size, Genome, and Classification

Poliovirus, the causative agent of poliomyelitis, belongs to the Picornaviridae family. Key virological features include:

• Diameter: Approximately 27–30 nanometers, making it one of the smallest known human viruses.
• Genome: A single‑stranded, positive‑sense RNA (ssRNA) of about 7,500 nucleotides, which functions directly as mRNA upon entry into the host cell.
• Capsid: Non‑enveloped, icosahedral capsid composed of 60 protomers, each containing VP1, VP2, VP3, and VP4 proteins.

The small size and simple genome of poliovirus facilitate rapid replication, but also present challenges for vaccine design, emphasizing the importance of the inactivated (Salk) and live‑attenuated (Sabin) vaccines.

6. Hepatitis B Virus (HBV): Antigenic Structure and Transmission

HBV is a partially double‑stranded DNA virus belonging to the Hepadnaviridae family. Its surface antigen, HbsAg (hepatitis B surface antigen), is a critical component for diagnosis, vaccination, and epidemiology.

• Composition: HbsAg consists of the small (S), medium (M), and large (L) surface proteins that are embedded in the viral envelope.
• Origin: These proteins are derived from the viral envelope (the “Dane particle”), not from the nucleocapsid core. The Dane particle is the complete, infectious virion of HBV.

Understanding the antigenic makeup of HbsAg is essential for interpreting serological tests (e.g., HBsAg positivity indicates active infection or carrier state) and for appreciating why the HBV vaccine, which contains recombinant HBsAg, is highly effective.

7. Primary Routes of HBV Transmission

HBV spreads predominantly through bloodborne pathways. The main routes include:

• Transfusion of contaminated blood or blood products.
• Sharing of needles or other injection equipment (e.g., among intravenous drug users).
• Occupational exposure for healthcare workers (needlestick injuries).

While sexual and perinatal transmission also occur, the quiz emphasizes that the principal route is via blood, underscoring the importance of strict infection‑control measures and universal vaccination programs.

8. Integrating Knowledge: Clinical Implications

Grasping the structural and pathogenic nuances of these viruses has direct clinical relevance:

• Herpesviruses: Recognizing CMV and EBV as agents that cause cytopathic effects helps in laboratory diagnosis (e.g., viral culture, PCR) and guides antiviral therapy (ganciclovir for CMV, rituximab for EBV‑related lymphoproliferative disease).
• Poliovirus: Understanding its small size and ssRNA genome reinforces the rationale behind oral polio vaccine (OPV) strategies and the need for continued surveillance to prevent re‑emergence.
• HBV: Knowledge of HbsAg’s envelope origin and bloodborne transmission informs public health policies, such as safe injection practices and the implementation of birth‑dose vaccination.

These concepts also serve as a foundation for advanced topics like viral latency, immune evasion, and vaccine development.

9. Frequently Asked Questions (FAQ)

Q: Why do only CMV and EBV cause noticeable cell lysis in culture?

A: Both viruses have strong cytopathic properties and can replicate to high titers in vitro, leading to visible CPE. Other herpesviruses, such as HSV‑1, often cause more subtle changes or require specific cell lines for optimal replication.

Q: Can HSV capsid size vary between HSV‑1 and HSV‑2?

A: The capsid architecture is conserved; both HSV‑1 and HSV‑2 share the 162‑capsomere icosahedral capsid, though minor differences exist in glycoprotein composition.

Q: How does the ssRNA genome of poliovirus affect its replication cycle?

A: The positive‑sense RNA can be directly translated by host ribosomes, allowing rapid production of viral proteins without the need for transcription, which accelerates the infection process.

Q: Why is HbsAg used in the HBV vaccine?

A: HbsAg is the major surface antigen that elicits a robust neutralizing antibody response, providing protective immunity without exposing recipients to infectious virus.

10. Summary and Key Take‑aways

To consolidate your learning, remember the following points:

• CMV and EBV are the herpesviruses that cause prominent cytopathic effects in cell culture.
• EBV uniquely stimulates lymphocyte proliferation, leading to conditions such as infectious mononucleosis and certain lymphomas.
• All herpesviruses contain double‑stranded DNA; their capsids consist of 162 capsomeres arranged in an icosahedral lattice.
• Poliovirus is a tiny (27–30 nm) non‑enveloped virus with a single‑stranded positive‑sense RNA genome.
• HbsAg originates from the envelope (Dane particle) of HBV and is the primary antigen used in vaccines.
• The main transmission route for HBV is bloodborne, highlighting the need for safe medical practices and vaccination.

By mastering these concepts, you will be better prepared for clinical examinations, laboratory diagnostics, and public‑health interventions related to viral diseases.